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Abstract 
Objective: To report a case of a substance-induced psychotic disorder secondary to 
ovulation induction therapy with gonadotrophins. 
Method: Case report. 
Results: We report a case of a psychotic episode secondary to gonadotrophins therapy. 
The acute episode was treated with antipsychotic (Aripiprazole). After two years  the 
patient remains free of psychotic symptoms. 
Conclusion: There have been several reports correlating low levels of estrogen with 
psychotic symptoms, leading to studies evaluating the possible effect of this hormone as 
an antipsychotic. In this case, we report psychotic symptoms with high levels of estradiol, 
which is contrary to that theory. 
 
1. Introduction  
Psychotic symptoms are common manifestations of a wide range of diseases, hence the 
mandatory exclusion of association with the direct physiological effects of a substance or 
another medical condition for most psychiatric diagnosis (1). Estrogen has been associated 
with a  potential  protective factor for psychosis in women. Evidence comes from studies 
on gender differences, investigation on estradiol levels and case reports (2)(3)(4)(5). We 
present a case of substance-induced psychotic disorder secondary to ovulation induction 
therapy with gonadotrophins. There have been several articles on psychological distress 
related to infertility treatments published. The most common psychological symptoms are 
anger, guilt, marital distress, lowered self-esteem, sexual dysfunction, social isolation, 
irritability, mood swings, feeling down, and bloating (6)(7). Psychotic symptoms are rare 
and to the best of our knowledge there is no reports of a similar case. 
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2. Case Report  
Mrs. F. is a 40-year-old married woman, with uterine pathology that caused secondary 
infertility. She tried five times to conceive using in vitro fertilization. On the last two 
attempts she used a combination of follitropin alfa and human menopausal 
gonadotrophin. Follitropin alfa is a preparation of recombinant human follicle-stimulating 
hormone (rhFSH), which stimulates ovarian follicular growth in women who do not have 
primary ovarian failure. Human menopausal gonadotrophin (HMG) is a combination of 
luteinizing hormone (LH) and follicle-stimulating hormone (FSH); it has a central role in 
ovulation induction. During her fourth ovarian stimulation, in May 2011, she suffered from 
headache and an unusual feeling that something was different with her. These feelings 
faded away in a few days without any medical intervention, and with no social impact. The 
infertility treatment was unsuccessful. In September 2011 she underwent her fifth ovarian 
stimulation, again with rhFSH and HMG. On the second day she developed auditory 
hallucinations (“I heard a man, a women and a child… they insulted me… they told me I 
was worthless”) and persecutory delusions (“I thought the neighbours were stealing 
electric power and cable television from us”), with periods of psychomotor agitation. She 
became functionally disturbed and was admitted to a private accident & emergency 
department, where she was prescribed Aripiprazole 15 mg per day after a clinical 
observation by an experienced psychiatrist, and a second psychiatric appointment was 
scheduled. After a few weeks, due to her unshakeable belief that the neighbors were 
stealing from them, the couple felt forced to move to another abode. She was then 
referred by her family doctor to a public hospital, where she was observed at triage. She 
had no psychotic symptoms, but was experiencing weakness, fatigue and loss of energy. 
She reported no personal or family history of psychiatric problems and denied any illicit 
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drug intake. Aripiprazole was reduced to 10mg per day while further investigation and 
family counseling were undertaken. Due to her uterine pathology, she suffered from 
menorrhagia and anaemia. Blood transfusions were prescribed and it was decided to 
proceed to hysterectomy. After discharge from Surgery, she had no complains except for 
regret that she didn’t consult a psychiatrist sooner (“that way maybe I would not have had 
to move house”). She had full insight to the psychotic episode, and felt sad because she did 
not like the new house. At April 2012 it was decided to stop Aripiprazole. After one month 
she was asymptomatic (May 2012). We kept her on periodic medical supervision. She 
remained asymptomatic until November 2013. At this point, her grandfather passed away 
and she was under uncommon pressure at work. She anticipated the appointment and 
presented with  anxiety symptoms associated with a terrible fear of becoming psychotic 
again. There was no evidence of positive psychotic symptoms. She was prescribed 
Clonazepam 0,5mg twice a day. After three weeks her anxiety was improved but she was 
not completely asymptomatic. She was prescribed Sertraline 25mg and discontinued 
Clonazepam (December 2013). After a few weeks she became asymptomatic, and by May 
2014 she  remained asymptomatic, with just treatment with Sertraline 25mg per day. We 
believe that this second episode has no relation to her previous psychotic one. Symptoms 
and circumstances were different. She gave informed consent for the publication of his 
case.  
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3. Discussion  
Several reports associate low estrogen levels with psychotic symptoms and its possible 
effect as an antipsychotic has been studied with no consistent results (8) (9). Against this, 
Choi et al. (2001) found no statistically significant relation between serum levels of 
estradiol and worsening of the symptoms in female schizophrenic inpatients (10). Those 
findings suggest that premenstrual exacerbation of symptoms in female patients may not 
be a worsening of the schizophrenic symptoms but a concurrence of affective, behavioral, 
and somatic symptoms. But the influence of estrogen on psychotic symptoms was noticed 
a long time ago by well known psychiatrists such as Krafft-Ebing, Kretschmer and Kraepelin 
(1909) (11). There is evidence that low estrogen levels are related to psychotic symptoms 
(12) (13) (5). In the present case, although no estrogens levels were available, but we can 
assume that they were high due to the ovarian stimulation pharmacotherapy. 
This is not the first case reporting psychotic episode or exacerbation of psychotic 
symptoms with high levels of estrogen. Siedentopf et al. reported a psychotic reaction to 
Clomiphene citrate, and they cited three similar cases (14); there was no reference to 
estradiol levels, but they were probably high secondary to Clomiphene citrate therapy, as 
that is a described effect of this substance (15). Our case is also contrary to the theory that 
estrogens acts on the brain as an antipsychotic (16). As in our case, Constant reported two 
cases where gonadotrophin hormone was associated with psychotic symptoms (17).It is 
still unknown how low estrogen levels produce psychotic symptoms. It may not be a direct 
correlation. We posited that in our case, the high estrogens levels might have enhanced 
dopamine activity. We can find in the literature some investigations suggesting the same 
(18)(19).Other authors agree and suggest that estrogen may provide a state of "decreased 
vulnerability" through changes in neurotransmitter systems without direct action on basic 
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pathophysiological mechanisms (20). We found no evidence in medical history, physical 
examination or auxiliary tests of another plausible cause for the psychotic symptoms. 
Supporting our hypothesis that in vitro fertilization was the cause, is the fact that the 
patient reported similar, although attenuated, symptoms after a previous treatment with 
the same substances. 
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